Abstract：Objective To analyze the efficacy of combined detection of brain natriuretic peptide（BNP）and urinary microalbumin/creatinine ratio（UACR）in the diagnosis of heart failure. Method A retrospective analysis was conducted on 74 patients with heart failure who were included in the observation group.Additionally,68 healthy individuals who underwent physical examinations at our hospital during the same period were included in the control group.Venous blood was collected from the two groups,and the differences in BNP and UACR were measured and compared;Draw a receiver operating curve（ROC）to analyze the efficacy of combining BNP and UACR in diagnosing heart failure.The results showed that the BNP and UACR of the observation group were（145.79±8.67）pg/mL and（36.89±4.47）mg/g,which were higher than those of the control group（76.21±6.05）pg/mL and（24.53±2.21）mg/g,with a statistical difference（P<0.05）;The ROC results showed that the area under the curve（AUC）of the combined detection of BNP and UACR was 0.914（95% CI：0.864~0.965）,which was higher than the 0.870（95% CI：0.807~0.932）and 0.820（95% CI：0.743~0.897）detected by the two alone. Conclusion BNP and UACR are abnormally high expressed in the body of patients with heart failure.The combination of the two can effectively diagnose heart failure and has high clinical application value,which can be vigorously promoted.
黄祖峰, 李铎, 翟雪艳. 脑钠肽与尿微量白蛋白/肌酐比值联合检测在心力衰竭诊断中应用研究[J]. 哈尔滨医药, 2024, 44(2): 5-7.
Huang Zufeng, Li Duo, Zhai Xueyan. Application of Combined Detection of Brain Natriuretic Peptide and Urinary Microalbumin/Creatinine Ratio in the Diagnosis of Heart Failure. journal1, 2024, 44(2): 5-7.
[1] Butler J,Packer M,Filippatos G,et al.Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction[J].Eur Heart J,2022,43(5):416-426. [2] Nielsen R,Jorsal A,Tougaard RS,et al.The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes[J].Diabetes Obes Metab,2020,22(11):2141-2150. [3] 乾叶子,杨威,吕媛媛,等.N端脑钠肽前体、可溶性人基质裂解素2及血小板/淋巴细胞比值对慢性心力衰竭的诊断价值[J].临床心血管病杂志,2021,37(3):239-243. [4] 崔泽岩,孙倩,周红霞.血清糖类抗原125和N末端B型脑钠肽前体对射血分数保留的心力衰竭的诊断与疗效判定及预后的评估价值[J].中国医药,2021,16(4):503-507. [5] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789. [6] 王冰,彭莉,刘伟.血清Cys C、B型脑钠肽与慢性心力衰竭的相关性研究[J].检验医学与临床,2021,(21):3109-3111. [7] 许抗抗,杨国爱,陈晓琳,等.NLR、MPV、脑钠肽评估心力衰竭病人预后的临床价值及其相关性分析[J].中西医结合心脑血管病杂志,2021,19(17):2970-2973. [8] 韩晶晶,王国林,李侃,等.血清氨基末端脑钠肽前体、白蛋白和同型半胱氨酸与射血分数保留型心力衰竭患者预后的相关性[J].岭南心血管病杂志,2022,28(1):63-66. [9] Colom G,Salvador JP,Acosta G,et al.Competitive ELISA for N-terminal pro-brain natriuretic peptide(NT-proBNP)determination in human plasma[J].Analyst,2020,145(20):6719-6727. [10] 赵鑫,朱蕾,强雪芹.血清IgE、BNP水平用于心力衰竭诊断的价值及其与部分血脂、心功能指标的相关性[J].检验医学与临床,2021,18(24):3591-3594. [11] 钱鹏,曹选超,徐先静,等.尿微量白蛋白/尿肌酐比值在老年充血性心力衰竭中的变化及临床价值探讨[J].中国卫生检验杂志,2020,30(18):2177-2179. [12] 梁佳莉,乐宇,高兴.尿微量白蛋白/尿肌酐比值在慢性心力衰竭患者中的变化分析[J].中国循证心血管医学杂志,2022,14(10):1248-1251.
2024, Vol. 44 
